Medical oncologist Lucio N. Gordan MD, president and managing physician of FCS, is lead author of the first real-world study comparing the two preferred regimens recommended for the primary treatment of non-transplant patients with newly-diagnosed multiple myeloma, published recently in Science Direct.
Padmaja Sai, MD, medical oncologist and hematologist with Florida Cancer Specialists & Research Institute, was presented last week with the AdventHealth Foundation 2023 Humanitarian of the Year Award.
No matter what life threw at her, Tarshia Rivera kept her faith. For Rivera, breast cancer was one more challenge that she had the confidence to overcome.
During the 2023 Florida Society of Clinical Oncology (FLASCO) Fall Session, several Florida Cancer Specialists & Research Institute, LLC (FCS) physicians were elected to serve as executive committee officers and chairs for the nationally recognized advocacy group in the upcoming term beginning January 1, 2024.
FCS is now offering an advanced maintenance therapy program that slows the progression of relapsed/refractory multiple myeloma (RRMM). The treatment, teclistamab (TECVAYLI®), is a type of rapidly evolving cancer therapy that uses the body’s immune system to fight cancer.
FCS Top News Updates
FCS Expands Clinical Team in Lake County, Welcomes Aamir Hussain to Statewide Practice